Thank you, readers! That's all from CNBC-TV18.com's live market coverage on February 22, 2022. Stay tuned for other updates on our website: CNBCTV18.com.
You can follow us on Twitter: @CNBCTV18Live @CNBCTV18News
And on Facebook, LinkedIn, Instagram and Telegram
Download our mobile app for Android and iOS platforms
Catch latest from CNBC-TV18's coverage of Russia-Ukraine conflict
Two clear problems in two-wheeler space: Anand Tandon
Market expert Anand Tandon is "not very bullish" on the two wheeler space, which, according to him, has two clear problems: the rural market is not doing well and it remains to be seen which of the many EV players will gain traction going forward.
He finds Eicher to be the best placed stock in the space. "On both counts, except if you are a company that makes a marquee brand that people want to buy because of nostalgic reasons, there is no particular reason to be in the sector for now," he adds.
Difficult to say how high will crude oil go: Probal Sen
Probal Sen, Analyst at ICICI Securities, says it is difficult to say how much crude oil will rise given the kind of crisis the market is facing. "If you add the fact that domestic gas prices are also likely to rise very sharply from April, to that extent, ONGC will benefit. We do not have official coverage (on ONGC) as of now," he says.
But directionally, ONGC will be a big beneficiary if crude and gas prices continue to spike, he adds.
Rerating in IT valuations driven by uplift in earnings growth rate: Nirav Sheth
Nirav Sheth, CEO-Institutional Equities at Emkay Global Financial Services, says IT PEs went from about 18 times forward earnings to about 32 times in the past two years, and are back to about 24-25 times. This rerating has been driven by an uplift in earnings growth rate, he says.
"Their CAGR in earnings till about FY20 was about 8-9 percent and has gone to about 15-16 percent. We believe that for FY23-24, we are likely to see double-digit growth in earnings. As things stand now, largecap IT is a better bet than midcap IT," he adds.
Indiabulls Real Estate a screaming buy: Mehraboon J Irani
Market expert Mehraboon J Irani believes Indiabulls Real Estate certainly qualifies as a decent valua pick from the real estate basket for investors with a horizon of 2-3 years. "I certainly believe there is money to be made over there," he says.
Mutual Fund Corner: Experts discuss if schemes should be judged against market or benchmark
In the latest episode of ‘Mutual Fund Corner’, CNBC-TV18’s Sumaira Abidi speaks with Lovaii Navlakhi of International Money Matters to discuss whether schemes should be judged against the market or the benchmark.
Market At Close | VIX hits 1-year high; geopolitical tensions in focus
Here are some highlights:
--India VIX rises to 1-year closing high of 26.7
--All sectoral indices in the red; media, realty, PSU bank top losers
--Market breath remains in favour of bears, improves to 1:5 from 1:20
--Tata Steel, BPCL, TCS, Tata Motors, SBI Life, SBI top Nifty losers
--M&M, Bajaj Finserv, Hero MotoCorp, Eicher, ONGC, Bajaj Auto top Nifty gainers
--DLF, Zee, Rain, MCX, Vodafone Idea, Strides, Godrej consumer top midcap losers
--Nippon Life, Apollo Hospitals, Nalco, Metropolis top midcap gainers
--TCS down 4 percent in 2 days
--ONGC among top nifty gainers as crude hits 7-year high, Brent above $99/barrel
--Hindalco, Nalco make sharp recovery from intraday lows on rising aluminium prices
--Barring Tata Motors, auto stocks see sharp recovery
--Dr Reddy’s down 2 percent; company has exposure to Russia, CIS
Tata Steel, BPCL, TCS, SBI, SBI Life, Tata Motors top blue-chip laggards
Dr Reddy's, Bharti Airtel, Indian Oil, HDFC Life and ITC also among the worst hit among the 33 losers in the Nifty50 universe. On the other hand, M&M, Bajaj Finserv, Hero MotoCorp, Eicher and Hindalco among gainers.
Here's how the 30-scrip pack fared:
Closing Bell: Sensex, Nifty end in red for fifth consecutive day; IT, Metals, Oil & Gas down; Realty worst-hit
Indian equity benchmark indices ended lower for the fifth consecutive session amid weak global cues due to Russia-Ukraine crisis. At close, the Sensex was down 382.91 points or 0.66 percent at 57300.68, and the Nifty was down 114.50 points or 0.67 percent at 17092.20. About 684 shares have advanced, 2589 shares declined, and 82 shares are unchanged.
Oil hits highest since 2014 on Russia-Ukraine escalation
Oil hit its highest since 2014 on Tuesday as tensions between Russia and Ukraine escalated after Moscow ordered troops into two breakaway regions in eastern Ukraine, adding to supply concerns that are pushing prices to near $100 a barrel.
How Russia-Ukraine conflict may impact this pure-play aluminium PSU stock
Aluminium prices have been moving up broadly on three factors. One is that energy cost has been spiking up, the second factor is a bit of a deficit because of lower production coming out of China and the third factor is that there has been some nervousness because of the escalating tension on the Russia-Ukraine front.
Sensex, Nifty50 drop as Russia-Ukraine crisis rattles global shares; should investors buy the dip?
Indian shares were deep in the red on Tuesday tracking weakness across global markets amid mounting geopolitical tensions after Russia ordered troops into two eastern Ukrainian regions. Financial, IT and oil & gas stocks were the biggest drags on both headline indices, Sensex and Nifty50, amid a broad-based sell-off.
Earlier in the day, the Sensex plunged as much as 1,288.7 points or 2.2 percent to 56,394.9 and the Nifty slid to as low as 16,843.8, shedding as much as 362.9 points or 2.1 percent from its previous close. Volatility also persisted ahead of the expiry of monthly derivatives contracts due on Thursday.
Indiabulls Real Estate up over 12%
Indiabulls Real Estate surged over 12 percent on Tuesday even as the market traded volatile with Ukraine-Russia crisis deepening. The gains came after the developer clarified that the recent Enforcement Directorate searches were about a client and had nothing to do with the company’s business or operations.
Marksans Pharma's UK arm gets UK MHRA nod for Bells Healthcare All-In-one oral solution
Marksans Pharma announced that UK MHRA has granted Market Authorisation to the company's wholly owned subsidiary Bell Sons & Co. (Druggists) Limited for Bells Healthcare All in One Oral Solution - used to treat Influenza. Marksans Pharma touched a 52-week low of Rs 47, down over 4 percent on Tuesday.